Mechanisms of Cancer Drug Resistance
Tóm tắt
▪ Abstract The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumors, even those from the same tissue of origin. Frequently resistance is intrinsic to the cancer, but as therapy becomes more and more effective, acquired resistance has also become common. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energy-dependent transporters that detect and eject anticancer drugs from cells, but other mechanisms of resistance including insensitivity to drug-induced apoptosis and induction of drug-detoxifying mechanisms probably play an important role in acquired anticancer drug resistance. Studies on mechanisms of cancer drug resistance have yielded important information about how to circumvent this resistance to improve cancer chemotherapy and have implications for pharmacokinetics of many commonly used drugs.
Từ khóa
Tài liệu tham khảo
Green SK, 1999, Anticancer-Drug Designs, 14, 153
Longo-Sorbello GS, 2001, Haematologica, 86, 121
Loe DW, 1998, Cancer Res., 58, 5130
Allikmets R, 1998, Cancer Res., 58, 5337
Miyake K, 1999, Cancer Res., 59, 8
Komatani H, 2001, Cancer Res., 61, 2827
Childs S, 1998, Cancer Res., 58, 4160
Laing NM, 1998, Cancer Res., 58, 1332
Lyall RM, 1987, Cancer Res., 47, 2961
Shen D-W, 1998, Cancer Res., 58, 268
Abolhoda A, 1999, Clin. Cancer Res., 5, 3352
Marie J-P, 1993, Leukemia, 7, 821
Crankshaw CL, 1998, J. Nucl. Med., 39, 77
Allen JD, 2000, Cancer Res., 60, 5761
Johnson DR, 2001, Cancer Res., 61, 1469
Gottesman MM, Licht T, Zhou Y, et al. 2000. Selectable markers for gene therapy. InGene Therapy: Therapeutic Mechanisms and Strategies, ed. D Lasic, N Templeton, 16:333–52. New York: Marcel Dekker